Cymabay Therapeutics Inc

+0.08 (+0.96%)
7:47:05 PM EDT: $8.39 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)794.35M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5 Million
Adjusted EPS-$0.26
See more estimates
10-Day MA$7.74
50-Day MA$5.37
200-Day MA$3.65
See more pivots

Cymabay Therapeutics Inc Stock, NASDAQ:CBAY

7575 Gateway Boulevard, Suite 110, Newark, California 94560
United States of America
Phone: +1.510.293.8800
Number of Employees: 59


CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.